Impact of Pharmaceutical R&D Activity on Financial Flexibility and Bargaining Power
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Thomas A. Abbott & John A. Vernon, 2007. "The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 293-306.
- Michael Kremer, 2002. "Pharmaceuticals and the Developing World," Journal of Economic Perspectives, American Economic Association, vol. 16(4), pages 67-90, Fall.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
- Harsha Thirumurthy & Joshua Graff Zivin & Markus Goldstein, 2008.
"The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya,"
Journal of Human Resources, University of Wisconsin Press, vol. 43(3), pages 511-552.
- Harsha Thirumurthy & Joshua Graff-Zivin & Markus Goldstein, 2005. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," NBER Working Papers 11871, National Bureau of Economic Research, Inc.
- Thirumurthy, Harsha & Zivin, Joshua Graff & Goldstein, Markus, 2006. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," Center Discussion Papers 28414, Yale University, Economic Growth Center.
- Harsha Thirumurthy & Joshua Graff Zivin & Markus Goldstein, 2006. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," Working Papers 947, Economic Growth Center, Yale University.
- Harsha Thirumurthy, 2005. "The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya," Working Papers id:300, eSocialSciences.
- Eric W. Bond & Kamal Saggi, 2023.
"Compulsory licensing, price controls, and access to patented foreign products,"
World Scientific Book Chapters, in: Kamal Saggi (ed.), Technology Transfer, Foreign Direct Investment, and the Protection of Intellectual Property in the Global Economy, chapter 19, pages 437-448,
World Scientific Publishing Co. Pte. Ltd..
- Bond, Eric W. & Saggi, Kamal, 2014. "Compulsory licensing, price controls, and access to patented foreign products," Journal of Development Economics, Elsevier, vol. 109(C), pages 217-228.
- Eric Saggi & Saggi Saggi, 2012. "Compulsory licensing, price controls, and access to patented foreign products," Vanderbilt University Department of Economics Working Papers 12-00006, Vanderbilt University Department of Economics.
- Gino A.Gancia, 2003.
"Globalization, Divergence and Stagnation,"
Development Working Papers
174, Centro Studi Luca d'Agliano, University of Milano.
- Gino Gancia, 2004. "Globalization, Divergence and Stagnation," 2004 Meeting Papers 63, Society for Economic Dynamics.
- Gancia, Gino, 2003. "Globalization, Divergence and Stagnation," Seminar Papers 720, Stockholm University, Institute for International Economic Studies.
- Gino Gancia, 2003. "Globalization, Divergence and Stagnation," Working Papers 198, Barcelona School of Economics.
- Barrero, Jose Maria & Bloom, Nick & Davis, Steven J., 2020.
"Why Working From Home Will Stick,"
SocArXiv
wfdbe, Center for Open Science.
- Jose Maria Barrero & Nicholas Bloom & Steven J. Davis, 2021. "Why working from home will stick," POID Working Papers 011, Centre for Economic Performance, LSE.
- Maria Barrero, Jose & Bloom, Nicholas & Davis, Steven J., 2021. "Why working from home will stick," LSE Research Online Documents on Economics 113912, London School of Economics and Political Science, LSE Library.
- Barrero, Jose Maria & Bloom, Nicholas & Davis, Steven J., 2021. "Why Working from Home Will Stick," Research Papers 3965, Stanford University, Graduate School of Business.
- Jose Maria Barrero & Nicholas Bloom & Steven J. Davis, 2021. "Why Working from Home Will Stick," NBER Working Papers 28731, National Bureau of Economic Research, Inc.
- Jose Maria Barrero & Nicholas Bloom & Steven J. Davis, 2020. "Why Working From Home Will Stick," Working Papers 2020-174, Becker Friedman Institute for Research In Economics.
- Jose Maria Barrero & Nicholas Bloom & Steven J. Davis, 2021. "Why working from home will stick," CEP Discussion Papers dp1790, Centre for Economic Performance, LSE.
- Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
- Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016.
"Patents and the Global Diffusion of New Drugs,"
American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
- Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
- Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
- Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
- Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
- Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
- Wang, Lucy Xiaolu, 2022. "Global drug diffusion and innovation with the medicines patent pool," Journal of Health Economics, Elsevier, vol. 85(C).
- Mujaheed Shaikh & Pietro Giudice & Dimitrios Kourouklis, 2021.
"Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment,"
Applied Health Economics and Health Policy, Springer, vol. 19(2), pages 217-229, March.
- Mujaheed Shaikh & Pietro del Giudice & Dimitrios Kourouklis, 2020. "Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment," Post-Print hal-03046856, HAL.
- Papageorgiou, Chris & Savvides, Andreas & Zachariadis, Marios, 2007.
"International medical technology diffusion,"
Journal of International Economics, Elsevier, vol. 72(2), pages 409-427, July.
- Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, 2005. "International Medical Technology Diffusion," University of Cyprus Working Papers in Economics 2-2005, University of Cyprus Department of Economics.
- Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, 2006. "International Medical Technology Diffsion," 2006 Meeting Papers 23, Society for Economic Dynamics.
- Adrian Towse;Jimena Ferraro;Jorge Mestre-Ferrandiz, 2017. "Incentives for New Drugs to Tackle Anti-Microbial Resistance," Briefing 001842, Office of Health Economics.
- David M. Cutler & Ellen Meara & Seth Richards-Shubik, 2012.
"Induced Innovation and Social Inequality: Evidence from Infant Medical Care,"
Journal of Human Resources, University of Wisconsin Press, vol. 47(2), pages 456-492.
- David M. Cutler & Ellen Meara & Seth Richards, 2009. "Induced Innovation and Social Inequality: Evidence from Infant Medical Care," NBER Working Papers 15316, National Bureau of Economic Research, Inc.
- Popp, David, 2012. "The role of technological change in green growth," Policy Research Working Paper Series 6239, The World Bank.
- Hyunju Rachel Kim, 2014. "Formulation of a Success Model in Pharmaceutical R&D," SAGE Open, , vol. 4(1), pages 21582440145, March.
- Grant Miller & Kimberly Singer Babiarz, 2013. "Pay-for-Performance Incentives in Low- and Middle-Income Country Health Programs," NBER Working Papers 18932, National Bureau of Economic Research, Inc.
- Banri ITO & Tatsufumi YAMAGATA, 2007.
"Who Develops Innovations In Medicine For The Poor? Trends In Patent Applications Related To Medicines For Hiv/Aids, Tuberculosis, Malaria, And Neglected Diseases,"
The Developing Economies, Institute of Developing Economies, vol. 45(2), pages 141-171, June.
- Ito, Banri & Yamagata, Tatsufumi, 2005. "Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases," IDE Discussion Papers 24, Institute of Developing Economies, Japan External Trade Organization(JETRO).
- Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(2), pages 185-208, April.
- Kyle, Margaret K. & Ridley, David B. & Zhang, Su, 2017.
"Strategic interaction among governments in the provision of a global public good,"
Journal of Public Economics, Elsevier, vol. 156(C), pages 185-199.
- Margaret Kyle & David Ridley & Su Zhang, 2017. "Strategic interaction among governments in the provision of a global public good," Post-Print hal-01952672, HAL.
- Kyle, Margaret & Ridley, David & Zhang, Su, 2017. "Strategic Interaction Among Governments in the Provision of a Global Public Good," CEPR Discussion Papers 12419, C.E.P.R. Discussion Papers.
- Margaret Kyle & David Ridley & Su Zhang, 2017. "Strategic interaction among governments in the provision of a global public good," Post-Print hal-01952712, HAL.
- Bastian Rake, 2017.
"Determinants of pharmaceutical innovation: the role of technological opportunities revisited,"
Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
- Bastian Rake, 2012. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," Jena Economics Research Papers 2012-018, Friedrich-Schiller-University Jena.
- Bastian Rake, 2013. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," DRUID Working Papers 13-03, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
- Cha Li & Felipe A. Csaszar, 2019. "Government as Landscape Designer: A Behavioral View of Industrial Policy," Strategy Science, INFORMS, vol. 4(3), pages 175-192, September.
More about this item
Keywords
pharmaceutical industry; R&D; bargaining power; cash cycle; industry leaders; development policies; panel regression; profitability;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jecomi:v:10:y:2022:i:11:p:277-:d:966415. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.